Mr. Aaron Li is a Vice President of Decheng Capital and has been with the firm since September 2018. Mr. Li currently serves on the boards of Bioheng and PackGene Biotech.
Prior to Decheng Capital, Mr. Li was a Consultant at Boston Consulting Group (BCG) where he focused healthcare practice covering various topics including: commercial excellence, emerging market strategy, growth strategy, turnaround, M&A strategy and post-merger integration support. The clients/partners he served include leading global pharmaceutical companies, medical technology companies, healthcare service providers as well as institutional investors. Prior to BCG, he worked for L.E.K. Consulting, a global management consulting firm with a focus on healthcare. Mr. Li received his Bachelor Degree of Economics from Shanghai University of International Business and Economics and Master of Business Administration (MBA) from Tuck School of Business at Dartmouth.